Aust J Gen Pract. 2021 Dec;50(12):880-885. doi: 10.31128/AJGP-05-21-6002.


Background: Melasma is a common disorder of hyperpigmentation of the skin, characterised by brown pigmentation primarily on the face. Given its frequent facial involvement, it has a significant impact on the quality of life of patients. Management can often be quite difficult, requiring extensive treatment periods and multiple modalities for ongoing maintenance.

Objective: The aim of this article is to provide evidence-based clinical updates to clinicians, specifically general practitioners, to assist with their everyday practice and effective assessment and treatment of melasma.

Discussion: Therapeutic modalities are chosen on the basis of disease presentation, patient preference, treatment periods and side-effect profiles of treatment agents; often a combination of therapies is required.

MeSH terms

  • Face
  • Humans
  • Hyperpigmentation*
  • Melanosis* / diagnosis
  • Melanosis* / therapy
  • Quality of Life
  • Skin